Oslo, Norway, 15 January 2025: Reference is made to the stock exchange announcement published by Lytix Biopharma AS ("Lytix" or the "Company") on 17 December 2024 (the "Announcement") regarding the successful completion of a private placement (the "Private Placement") of new shares raising NOK 100 million in gross proceeds, and …
